|Accueil||Recherche||Nouveautés||Email webmaster||Tous les textes - FMC||Sommaire général||Page précédente|
Breast cancer mortality in organised mammography
screening in Denmark
Karsten Juhl Jørgensen, researcher1, Per-Henrik Zahl, senior researcher2, Peter C Gøtzsche, professor1
1 The Nordic Cochrane Centre, Rigshospitalet, University of Copenhagen, Denmark, 2 Norwegian Institute of Public Health, Oslo, Norway
BMJ 2010;340 : http://www.bmj.com/cgi/content/full/340/mar23_1/c1241
Leurs conclusions sont que , la mortalité par cancer du sein des femmes bénéficiant du dépistage a baissé de 1 % par an dans les régions danoises où il avait cours.
Mais la baisse était de 2 % par an dans les zones non concernées par le dépistage.
Ils remarquent aussi que chez les femmes trop jeunes pour être dépistées, la mortalité par cancer du sein a baissé de 5 % par an pendant les 10 dernières années et que dans certaines régions du pays, la diminution de la mortalité avait commencé avant la mise en place des programmes de dépistage.
Les baisses de la mortalité constatées seraient due plutôt à des modifications des facteurs de risque et aux progrès thérapeutiques réalisés dans la prise en charge des cancers au cours de la dernière décénie.
Objective To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up.
Design We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast cancer mortality in areas where screening was used with the change in areas where it was not used during 10 years before screening was introduced and for 10 years after screening was in practice (starting five years after introduction of screening).
Setting Copenhagen, where mammography screening started in 1991, and Funen county, where screening was introduced in 1993. The rest of Denmark (about 80% of the population) served as an unscreened control group.
Participants All Danish women recorded in the Cause of Death Register and Statistics Denmark for 1971-2006.
Main outcome measure Annual percentage change in breast cancer mortality in regions offering mammography screening and those not offering screening.
Results In women who could benefit from screening (ages 55-74 years), we found a mortality decline of 1% per year in the screening areas (relative risk (RR) 0.99, 95% confidence interval (CI) 0.96 to 1.01) during the 10 year period when screening could have had an effect (1997-2006). In women of the same age in the non-screening areas, there was a decline of 2% in mortality per year (RR 0.98, 95% CI 0.97 to 0.99) in the same 10 year period. In women who were too young to benefit from screening (ages 35-55 years), breast cancer mortality during 1997-2006 declined 5% per year (RR 0.95, CI 0.92 to 0.98) in the screened areas and 6% per year (RR 0.94, CI 0.92 to 0.95) in the non-screened areas. For the older age groups (75-84 years), there was little change in breast cancer mortality over time in both screened and non-screened areas. Trends were less clear during the 10 year period before screening was introduced, with a possible increase in mortality in women aged less than 75 years in the non-screened regions.
Conclusions We were unable to find an effect of the Danish screening programme on breast cancer mortality. The reductions in breast cancer mortality we observed in screening regions were similar or less than those in non-screened areas and in age groups too young to benefit from screening, and are more likely explained by changes in risk factors and improved treatment than by screening mammography.
Number of breast cancer deaths in screened and nonscreened areas [Lire] (pdf)
|Accueil||Nouveautés||Email webmaster||Sommaire FMC||Sommaire général||Page précédente|